iecs.org.ar

The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees

M. Taljaard,C. Weijer,J. M. Grimshaw and M. P. Eccles. The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees. Bmj. 2013;346:10.1136/bmj.f2838.

The Ottawa Statement on the ethical design and conduct of cluster randomised trials: precis for researchers and research ethics committees Ver más »

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk

D. Spiegelman,L. C. Lovato,P. Khudyakov,T. L. Wilkens,C. A. Adebamowo,S. N. Adebamowo,L. J. Appel,J. W. Beulens,J. W. Coughlin,L. O. Dragsted,H. J. Edenberg,J. N. Eriksen,R. Estruch,D. E. Grobbee,P. E. Gulayin,V. Irazola,J. H. Krystal,M. Lazo,M. M. Murray,E. B. Rimm,I. C. Schrieks,J. D. Williamson and K. J. Mukamal. The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods

The Moderate Alcohol and Cardiovascular Health Trial (MACH15): Design and methods for a randomized trial of moderate alcohol consumption and cardiometabolic risk Ver más »

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries

A. Aifah,J. Iwelunmor,C. Akwanalo,J. Allison,A. Amberbir,K. P. Asante,A. Baumann,A. Brown,M. Butler,M. Dalton,V. Davila-Roman,A. L. Fitzpatrick,M. Fort,R. Goldberg,A. Gondwe,D. Ha,J. He,M. Hosseinipour,V. Irazola,J. Kamano,S. Karengera,B. M. Karmacharya,R. Koju,R. Maharjan,S. Mohan,V. Mutabazi,E. Mutimura,A. Muula,K. M. V. Narayan,H. Nguyen,B. Njuguna,M. Nyirenda,G. Ogedegbe,J. van Oosterhout,D. Onakomaiya,S. Patel,A. Paniagua-Ávila,M. Ramirez-Zea,J. Plange-Rhule,D. Roche,A. Shrestha,H. Sharma,N. Tandon,N. Thu-Cuc,A. Vaidya,R. Vedanthan and M.

The Kathmandu Declaration on Global CVD/Hypertension Research and Implementation Science: A Framework to Advance Implementation Research for Cardiovascular and Other Noncommunicable Diseases in Low- and Middle-Income Countries Ver más »

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome

M. Gerde,E. Ibarra,R. Mac Kenzie,C. Fernandez Suarez,C. Heer,R. Alvarez,M. Iglesias,J. Balparda,E. Beruti and F. Rubinstein. The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome. Thrombosis Research. 2021;206:10.1016/j.thromres.2021.08.004.

The impact of hydroxychloroquine on obstetric outcomes in refractory obstetric antiphospholipid syndrome Ver más »

The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago

A. La Foucade,C. Laptiste,A. Alcaraz,K. Theodore,A. Cumberbatch,K. A. Gittens-Baynes,V. Beharry,S. Gabriel,C. Metivier,P. Edwards-Wescott and D. Bethelmie. The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago. Nutr Health. 2023:10.1177/02601060231156117.

The health and economic burden associated with sugar-sweetened beverage consumption in Trinidad and Tobago Ver más »

The global network antenatal corticosteroids trial: impact on stillbirth

R. L. Goldenberg,V. R. Thorsten,F. Althabe,S. Saleem,A. Garces,W. A. Carlo,O. Pasha,E. Chomba,S. Goudar,F. Esamai,N. F. Krebs,R. J. Derman,E. A. Liechty,A. Patel,P. L. Hibberd,P. M. Buekens,M. Koso-Thomas,M. Miodovnik,A. H. Jobe,D. D. Wallace,J. M. Belizán and E. M. McClure. The global network antenatal corticosteroids trial: impact on stillbirth. Reprod Health. 2016;13(1):10.1186/s12978-016-0174-4.

The global network antenatal corticosteroids trial: impact on stillbirth Ver más »